We silenced PTK6 gene expression with two different well-validated shRNAs (28) in the PC-3 and C4-2B prostate cancer cell lines, the lung cancer cell line PC-9, and the breast cancer cell line T47-D. The gene discussed is PTK6; the disease is breast carcinoma.